Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

被引：0
|
作者：
Aubuchon, JP
Herschel, L
Roger, J
Taylor, H
Whitley, P
Li, J
Edrich, R
Goodrich, RP
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[3] Navigant Biotechnol Inc, Lakewood, CO USA
来源：
TRANSFUSION | 2004年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：16A / 17A
页数：2
相关论文
共 50 条
  • [31] Effects of Intercept pathogen reduction treatment on extended cold storage of apheresis platelets
    Agey, Alisa
    Reddoch-Cardenas, Kristin
    McIntosh, Colby
    Sharma, Umang
    Cantu, Carolina
    Cap, Andrew
    Bynum, James
    TRANSFUSION, 2021, 61 (01) : 167 - 177
  • [32] Annexin V Release and Transmembrane Mitochondrial Potential during Storage of Apheresis-Derived Platelets Treated for Pathogen Reduction
    Picker, Susanne M.
    Oustianskaia, Larissa
    Schneider, Volker
    Gathof, Birgit S.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2010, 37 (01) : 7 - 12
  • [33] Efficacy and Safety of Pathogen-Reduced Platelets Compared with Standard Apheresis Platelets: A Systematic Review of RCTs
    Pati, Ilaria
    Masiello, Francesca
    Pupella, Simonetta
    Cruciani, Mario
    De Angelis, Vincenzo
    PATHOGENS, 2022, 11 (06):
  • [34] The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets
    Castro, Emma
    Miguel Gonzalez, Luis
    Miguel Rubio, Jose
    Ramiro, Raquel
    Girones, Nuria
    Montero, Estrella
    TRANSFUSION, 2014, 54 (09) : 2207 - 2216
  • [35] In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets
    Tynngard, Nahreen
    Trinks, Marie
    Berlin, Goesta
    TRANSFUSION, 2015, 55 (06) : 1169 - 1177
  • [36] Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial
    Snyder, E
    McCullough, J
    Slichter, SJ
    Strauss, RG
    Lopez-Plaza, I
    Lin, JS
    Corash, L
    Conlan, MG
    TRANSFUSION, 2005, 45 (12) : 1864 - 1875
  • [37] Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro
    Zeddies, Sabrina
    De Cuyper, Iris M.
    van der Meer, Pieter F.
    Daal, Brunette B.
    de Korte, Dirk
    Gutierrez, Laura
    Thijssen-Timmer, Daphne C.
    TRANSFUSION, 2014, 54 (09) : 2292 - 2300
  • [38] Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells
    Tormey, Christopher A.
    Santhanakrishnan, Manjula
    Smith, Nicole H.
    Liu, Jingchun
    Marschner, Susanne
    Goodrich, Raymond P.
    Hendrickson, Jeanne E.
    TRANSFUSION, 2016, 56 (04) : 863 - 872
  • [39] The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood
    Jimenez-Marco, Teresa
    Cancino-Faure, Beatriz
    Girona-Llobera, Enrique
    Magdalena Alcover, M.
    Riera, Cristina
    Fisa, Roser
    TRANSFUSION, 2017, 57 (06) : 1440 - 1447
  • [40] Preservation of neutralizing antibody function in COVID-19 convalescent plasma treated using a riboflavin and ultraviolet light-based pathogen reduction technology
    Yonemura, Susan
    Hartson, Lindsay
    Dutt, Taru S.
    Henao-Tamayo, Marcela
    Goodrich, Raymond
    Marschner, Susanne
    VOX SANGUINIS, 2021, 116 (10) : 1076 - 1083
12345